Skip to content
BIO FRONTIER
Home
Artificial intelligence
Biotechnology
Genetics
Medical Technology
ALPMF
Home
ALPMF
ALPMF
ALPMY
Biotechnology
Uncategorized
VIR
Vir surges on up to $1.7B deal with Astellas to advance prostate cancer asset
Feb 23, 2026
Search for: